Andreas Kluge
Oprichter bij TELIX PHARMACEUTICALS LIMITED
Vermogen: 222 M $ op 30-04-2024
Actieve functies van Andreas Kluge
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Directeur/Bestuurslid | 03-01-2017 | - |
| Oprichter | 01-11-2015 | - | |
| Hoofd Techniek/Wetenschap/O&O | 03-01-2017 | 02-06-2020 | |
Therapeia GmbH & Co. Kg
 Therapeia GmbH & Co. Kg Pharmaceuticals: MajorHealth Technology Therapeia GmbH & Co. Kg provides diagnostic and therapeutic radiopharmaceuticals. The firm offers treatment for brain cancer. The company was founded by Andreas Kluge in 2007 and is headquartered in Dresden, Germany. | Algemeen Directeur | 01-01-2007 | - |
| Oprichter | 01-01-2007 | - | |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2007 | - | |
| ABX-CRO advanced pharmaceutical services | Hoofd Techniek/Wetenschap/O&O | 01-08-2002 | - |
| Oprichter | 01-08-2002 | - |
Loopbaan van Andreas Kluge
Eerdere bekende functies van Andreas Kluge
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
ABX advanced biochemical compounds GmbH
 ABX advanced biochemical compounds GmbH Chemicals: SpecialtyProcess Industries Part of Otsuka Holdings Co., Ltd., ABX advanced biochemical compounds GmbH is a German company that manufactures chemicals for nuclear medicine applications. The company is based in Radeburg, Germany. The company was founded by Andreas Kluge. Andreas Kluge has been the CEO since incorporation. ABX advanced biochemical compounds was acquired by Cambridge Isotope Laboratories, Inc. on September 20, 2006. | Algemeen Directeur | 01-09-1996 | 01-07-2002 |
| Oprichter | 01-09-1996 | 01-07-2002 |
Opleiding van Andreas Kluge
| Freie Universität Berlin | Doctorate Degree |
Statistieken
Internationaal
| Duitsland | 5 |
| Australië | 2 |
Operationeel
| Founder | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Chief Executive Officer | 2 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
| Process Industries | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TELIX PHARMACEUTICALS LIMITED | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
ABX advanced biochemical compounds GmbH
ABX advanced biochemical compounds GmbH Chemicals: SpecialtyProcess Industries Part of Otsuka Holdings Co., Ltd., ABX advanced biochemical compounds GmbH is a German company that manufactures chemicals for nuclear medicine applications. The company is based in Radeburg, Germany. The company was founded by Andreas Kluge. Andreas Kluge has been the CEO since incorporation. ABX advanced biochemical compounds was acquired by Cambridge Isotope Laboratories, Inc. on September 20, 2006. | Process Industries |
Therapeia GmbH & Co. Kg
Therapeia GmbH & Co. Kg Pharmaceuticals: MajorHealth Technology Therapeia GmbH & Co. Kg provides diagnostic and therapeutic radiopharmaceuticals. The firm offers treatment for brain cancer. The company was founded by Andreas Kluge in 2007 and is headquartered in Dresden, Germany. | Health Technology |
| ABX-CRO advanced pharmaceutical services |
- Beurs
- Insiders
- Andreas Kluge
- Ervaring
